Global Neoantigen Targeted Therapy Market Research Report 2023
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neoantigen Targeted Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
By Company
- BioNTech SE
- Gritstone Bio
- Genocea Biosciences
- Moderna
- Agenus
- Immatics
- Advaxis
- Precision Biologics
- Gilead Sciences
- Cellular Biomedicine Group
- Achilles Therapeutics
- Merck and Co
- Beijing Kati Medical Technology
- Off-the-shelf Neoantigen
- Personalized Neoantigen
- Colorectal Cancer
- Renal Cell Carcinoma
- Non-Small Cell Lung cancer
- Bone Cancer
- Gynecological Cancer
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Off-the-shelf Neoantigen
1.2.3 Personalized Neoantigen
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Colorectal Cancer
1.3.3 Renal Cell Carcinoma
1.3.4 Non-Small Cell Lung cancer
1.3.5 Bone Cancer
1.3.6 Gynecological Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Neoantigen Targeted Therapy Market Perspective (2018-2029)
2.2 Neoantigen Targeted Therapy Growth Trends by Region
2.2.1 Global Neoantigen Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neoantigen Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029)
2.3 Neoantigen Targeted Therapy Market Dynamics
2.3.1 Neoantigen Targeted Therapy Industry Trends
2.3.2 Neoantigen Targeted Therapy Market Drivers
2.3.3 Neoantigen Targeted Therapy Market Challenges
2.3.4 Neoantigen Targeted Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Neoantigen Targeted Therapy Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapy Players by Revenue (2018-2023)
3.1.2 Global Neoantigen Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neoantigen Targeted Therapy Revenue
3.4 Global Neoantigen Targeted Therapy Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapy Revenue in 2022
3.5 Neoantigen Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Neoantigen Targeted Therapy Product Solution and Service
3.7 Date of Enter into Neoantigen Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NEOANTIGEN TARGETED THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Neoantigen Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029)
5 NEOANTIGEN TARGETED THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Neoantigen Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neoantigen Targeted Therapy Market Size (2018-2029)
6.2 North America Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neoantigen Targeted Therapy Market Size by Country (2018-2023)
6.4 North America Neoantigen Targeted Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
7.2 Europe Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023)
7.4 Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Neoantigen Targeted Therapy Market Size (2018-2029)
8.2 Asia-Pacific Neoantigen Targeted Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Neoantigen Targeted Therapy Market Size (2018-2029)
9.2 Latin America Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023)
9.4 Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neoantigen Targeted Therapy Market Size (2018-2029)
10.2 Middle East & Africa Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 BioNTech SE
11.1.1 BioNTech SE Company Detail
11.1.2 BioNTech SE Business Overview
11.1.3 BioNTech SE Neoantigen Targeted Therapy Introduction
11.1.4 BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.1.5 BioNTech SE Recent Development
11.2 Gritstone Bio
11.2.1 Gritstone Bio Company Detail
11.2.2 Gritstone Bio Business Overview
11.2.3 Gritstone Bio Neoantigen Targeted Therapy Introduction
11.2.4 Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.2.5 Gritstone Bio Recent Development
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Company Detail
11.3.2 Genocea Biosciences Business Overview
11.3.3 Genocea Biosciences Neoantigen Targeted Therapy Introduction
11.3.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.3.5 Genocea Biosciences Recent Development
11.4 Moderna
11.4.1 Moderna Company Detail
11.4.2 Moderna Business Overview
11.4.3 Moderna Neoantigen Targeted Therapy Introduction
11.4.4 Moderna Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.4.5 Moderna Recent Development
11.5 Agenus
11.5.1 Agenus Company Detail
11.5.2 Agenus Business Overview
11.5.3 Agenus Neoantigen Targeted Therapy Introduction
11.5.4 Agenus Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.5.5 Agenus Recent Development
11.6 Immatics
11.6.1 Immatics Company Detail
11.6.2 Immatics Business Overview
11.6.3 Immatics Neoantigen Targeted Therapy Introduction
11.6.4 Immatics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.6.5 Immatics Recent Development
11.7 Advaxis
11.7.1 Advaxis Company Detail
11.7.2 Advaxis Business Overview
11.7.3 Advaxis Neoantigen Targeted Therapy Introduction
11.7.4 Advaxis Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.7.5 Advaxis Recent Development
11.8 Precision Biologics
11.8.1 Precision Biologics Company Detail
11.8.2 Precision Biologics Business Overview
11.8.3 Precision Biologics Neoantigen Targeted Therapy Introduction
11.8.4 Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.8.5 Precision Biologics Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Neoantigen Targeted Therapy Introduction
11.9.4 Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.9.5 Gilead Sciences Recent Development
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Detail
11.10.2 Cellular Biomedicine Group Business Overview
11.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Introduction
11.10.4 Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.10.5 Cellular Biomedicine Group Recent Development
11.11 Achilles Therapeutics
11.11.1 Achilles Therapeutics Company Detail
11.11.2 Achilles Therapeutics Business Overview
11.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Introduction
11.11.4 Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.11.5 Achilles Therapeutics Recent Development
11.12 Merck and Co
11.12.1 Merck and Co Company Detail
11.12.2 Merck and Co Business Overview
11.12.3 Merck and Co Neoantigen Targeted Therapy Introduction
11.12.4 Merck and Co Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.12.5 Merck and Co Recent Development
11.13 Beijing Kati Medical Technology
11.13.1 Beijing Kati Medical Technology Company Detail
11.13.2 Beijing Kati Medical Technology Business Overview
11.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Introduction
11.13.4 Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.13.5 Beijing Kati Medical Technology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Off-the-shelf Neoantigen
1.2.3 Personalized Neoantigen
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Colorectal Cancer
1.3.3 Renal Cell Carcinoma
1.3.4 Non-Small Cell Lung cancer
1.3.5 Bone Cancer
1.3.6 Gynecological Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Neoantigen Targeted Therapy Market Perspective (2018-2029)
2.2 Neoantigen Targeted Therapy Growth Trends by Region
2.2.1 Global Neoantigen Targeted Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Neoantigen Targeted Therapy Historic Market Size by Region (2018-2023)
2.2.3 Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029)
2.3 Neoantigen Targeted Therapy Market Dynamics
2.3.1 Neoantigen Targeted Therapy Industry Trends
2.3.2 Neoantigen Targeted Therapy Market Drivers
2.3.3 Neoantigen Targeted Therapy Market Challenges
2.3.4 Neoantigen Targeted Therapy Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Neoantigen Targeted Therapy Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapy Players by Revenue (2018-2023)
3.1.2 Global Neoantigen Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Neoantigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neoantigen Targeted Therapy Revenue
3.4 Global Neoantigen Targeted Therapy Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapy Revenue in 2022
3.5 Neoantigen Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Neoantigen Targeted Therapy Product Solution and Service
3.7 Date of Enter into Neoantigen Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NEOANTIGEN TARGETED THERAPY BREAKDOWN DATA BY TYPE
4.1 Global Neoantigen Targeted Therapy Historic Market Size by Type (2018-2023)
4.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029)
5 NEOANTIGEN TARGETED THERAPY BREAKDOWN DATA BY APPLICATION
5.1 Global Neoantigen Targeted Therapy Historic Market Size by Application (2018-2023)
5.2 Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Neoantigen Targeted Therapy Market Size (2018-2029)
6.2 North America Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Neoantigen Targeted Therapy Market Size by Country (2018-2023)
6.4 North America Neoantigen Targeted Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Neoantigen Targeted Therapy Market Size (2018-2029)
7.2 Europe Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023)
7.4 Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Neoantigen Targeted Therapy Market Size (2018-2029)
8.2 Asia-Pacific Neoantigen Targeted Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Neoantigen Targeted Therapy Market Size (2018-2029)
9.2 Latin America Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023)
9.4 Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neoantigen Targeted Therapy Market Size (2018-2029)
10.2 Middle East & Africa Neoantigen Targeted Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 BioNTech SE
11.1.1 BioNTech SE Company Detail
11.1.2 BioNTech SE Business Overview
11.1.3 BioNTech SE Neoantigen Targeted Therapy Introduction
11.1.4 BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.1.5 BioNTech SE Recent Development
11.2 Gritstone Bio
11.2.1 Gritstone Bio Company Detail
11.2.2 Gritstone Bio Business Overview
11.2.3 Gritstone Bio Neoantigen Targeted Therapy Introduction
11.2.4 Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.2.5 Gritstone Bio Recent Development
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Company Detail
11.3.2 Genocea Biosciences Business Overview
11.3.3 Genocea Biosciences Neoantigen Targeted Therapy Introduction
11.3.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.3.5 Genocea Biosciences Recent Development
11.4 Moderna
11.4.1 Moderna Company Detail
11.4.2 Moderna Business Overview
11.4.3 Moderna Neoantigen Targeted Therapy Introduction
11.4.4 Moderna Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.4.5 Moderna Recent Development
11.5 Agenus
11.5.1 Agenus Company Detail
11.5.2 Agenus Business Overview
11.5.3 Agenus Neoantigen Targeted Therapy Introduction
11.5.4 Agenus Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.5.5 Agenus Recent Development
11.6 Immatics
11.6.1 Immatics Company Detail
11.6.2 Immatics Business Overview
11.6.3 Immatics Neoantigen Targeted Therapy Introduction
11.6.4 Immatics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.6.5 Immatics Recent Development
11.7 Advaxis
11.7.1 Advaxis Company Detail
11.7.2 Advaxis Business Overview
11.7.3 Advaxis Neoantigen Targeted Therapy Introduction
11.7.4 Advaxis Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.7.5 Advaxis Recent Development
11.8 Precision Biologics
11.8.1 Precision Biologics Company Detail
11.8.2 Precision Biologics Business Overview
11.8.3 Precision Biologics Neoantigen Targeted Therapy Introduction
11.8.4 Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.8.5 Precision Biologics Recent Development
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Detail
11.9.2 Gilead Sciences Business Overview
11.9.3 Gilead Sciences Neoantigen Targeted Therapy Introduction
11.9.4 Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.9.5 Gilead Sciences Recent Development
11.10 Cellular Biomedicine Group
11.10.1 Cellular Biomedicine Group Company Detail
11.10.2 Cellular Biomedicine Group Business Overview
11.10.3 Cellular Biomedicine Group Neoantigen Targeted Therapy Introduction
11.10.4 Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.10.5 Cellular Biomedicine Group Recent Development
11.11 Achilles Therapeutics
11.11.1 Achilles Therapeutics Company Detail
11.11.2 Achilles Therapeutics Business Overview
11.11.3 Achilles Therapeutics Neoantigen Targeted Therapy Introduction
11.11.4 Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.11.5 Achilles Therapeutics Recent Development
11.12 Merck and Co
11.12.1 Merck and Co Company Detail
11.12.2 Merck and Co Business Overview
11.12.3 Merck and Co Neoantigen Targeted Therapy Introduction
11.12.4 Merck and Co Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.12.5 Merck and Co Recent Development
11.13 Beijing Kati Medical Technology
11.13.1 Beijing Kati Medical Technology Company Detail
11.13.2 Beijing Kati Medical Technology Business Overview
11.13.3 Beijing Kati Medical Technology Neoantigen Targeted Therapy Introduction
11.13.4 Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2018-2023)
11.13.5 Beijing Kati Medical Technology Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Neoantigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Off-the-shelf Neoantigen
Table 3. Key Players of Personalized Neoantigen
Table 4. Global Neoantigen Targeted Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Neoantigen Targeted Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neoantigen Targeted Therapy Market Share by Region (2018-2023)
Table 8. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neoantigen Targeted Therapy Market Share by Region (2024-2029)
Table 10. Neoantigen Targeted Therapy Market Trends
Table 11. Neoantigen Targeted Therapy Market Drivers
Table 12. Neoantigen Targeted Therapy Market Challenges
Table 13. Neoantigen Targeted Therapy Market Restraints
Table 14. Global Neoantigen Targeted Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neoantigen Targeted Therapy Market Share by Players (2018-2023)
Table 16. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Table 17. Ranking of Global Top Neoantigen Targeted Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neoantigen Targeted Therapy Product Solution and Service
Table 21. Date of Enter into Neoantigen Targeted Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. BioNTech SE Company Detail
Table 47. BioNTech SE Business Overview
Table 48. BioNTech SE Neoantigen Targeted Therapy Product
Table 49. BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 50. BioNTech SE Recent Development
Table 51. Gritstone Bio Company Detail
Table 52. Gritstone Bio Business Overview
Table 53. Gritstone Bio Neoantigen Targeted Therapy Product
Table 54. Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 55. Gritstone Bio Recent Development
Table 56. Genocea Biosciences Company Detail
Table 57. Genocea Biosciences Business Overview
Table 58. Genocea Biosciences Neoantigen Targeted Therapy Product
Table 59. Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 60. Genocea Biosciences Recent Development
Table 61. Moderna Company Detail
Table 62. Moderna Business Overview
Table 63. Moderna Neoantigen Targeted Therapy Product
Table 64. Moderna Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Agenus Company Detail
Table 67. Agenus Business Overview
Table 68. Agenus Neoantigen Targeted Therapy Product
Table 69. Agenus Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 70. Agenus Recent Development
Table 71. Immatics Company Detail
Table 72. Immatics Business Overview
Table 73. Immatics Neoantigen Targeted Therapy Product
Table 74. Immatics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 75. Immatics Recent Development
Table 76. Advaxis Company Detail
Table 77. Advaxis Business Overview
Table 78. Advaxis Neoantigen Targeted Therapy Product
Table 79. Advaxis Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 80. Advaxis Recent Development
Table 81. Precision Biologics Company Detail
Table 82. Precision Biologics Business Overview
Table 83. Precision Biologics Neoantigen Targeted Therapy Product
Table 84. Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 85. Precision Biologics Recent Development
Table 86. Gilead Sciences Company Detail
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Neoantigen Targeted Therapy Product
Table 89. Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Cellular Biomedicine Group Company Detail
Table 92. Cellular Biomedicine Group Business Overview
Table 93. Cellular Biomedicine Group Neoantigen Targeted Therapy Product
Table 94. Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 95. Cellular Biomedicine Group Recent Development
Table 96. Achilles Therapeutics Company Detail
Table 97. Achilles Therapeutics Business Overview
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Product
Table 99. Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 100. Achilles Therapeutics Recent Development
Table 101. Merck and Co Company Detail
Table 102. Merck and Co Business Overview
Table 103. Merck and Co Neoantigen Targeted Therapy Product
Table 104. Merck and Co Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 105. Merck and Co Recent Development
Table 106. Beijing Kati Medical Technology Company Detail
Table 107. Beijing Kati Medical Technology Business Overview
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product
Table 109. Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 110. Beijing Kati Medical Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 1. Global Neoantigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Off-the-shelf Neoantigen
Table 3. Key Players of Personalized Neoantigen
Table 4. Global Neoantigen Targeted Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Neoantigen Targeted Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neoantigen Targeted Therapy Market Share by Region (2018-2023)
Table 8. Global Neoantigen Targeted Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Neoantigen Targeted Therapy Market Share by Region (2024-2029)
Table 10. Neoantigen Targeted Therapy Market Trends
Table 11. Neoantigen Targeted Therapy Market Drivers
Table 12. Neoantigen Targeted Therapy Market Challenges
Table 13. Neoantigen Targeted Therapy Market Restraints
Table 14. Global Neoantigen Targeted Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neoantigen Targeted Therapy Market Share by Players (2018-2023)
Table 16. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Table 17. Ranking of Global Top Neoantigen Targeted Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neoantigen Targeted Therapy Product Solution and Service
Table 21. Date of Enter into Neoantigen Targeted Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neoantigen Targeted Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Neoantigen Targeted Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Neoantigen Targeted Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Neoantigen Targeted Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Neoantigen Targeted Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Neoantigen Targeted Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Neoantigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neoantigen Targeted Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Neoantigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neoantigen Targeted Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. BioNTech SE Company Detail
Table 47. BioNTech SE Business Overview
Table 48. BioNTech SE Neoantigen Targeted Therapy Product
Table 49. BioNTech SE Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 50. BioNTech SE Recent Development
Table 51. Gritstone Bio Company Detail
Table 52. Gritstone Bio Business Overview
Table 53. Gritstone Bio Neoantigen Targeted Therapy Product
Table 54. Gritstone Bio Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 55. Gritstone Bio Recent Development
Table 56. Genocea Biosciences Company Detail
Table 57. Genocea Biosciences Business Overview
Table 58. Genocea Biosciences Neoantigen Targeted Therapy Product
Table 59. Genocea Biosciences Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 60. Genocea Biosciences Recent Development
Table 61. Moderna Company Detail
Table 62. Moderna Business Overview
Table 63. Moderna Neoantigen Targeted Therapy Product
Table 64. Moderna Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 65. Moderna Recent Development
Table 66. Agenus Company Detail
Table 67. Agenus Business Overview
Table 68. Agenus Neoantigen Targeted Therapy Product
Table 69. Agenus Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 70. Agenus Recent Development
Table 71. Immatics Company Detail
Table 72. Immatics Business Overview
Table 73. Immatics Neoantigen Targeted Therapy Product
Table 74. Immatics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 75. Immatics Recent Development
Table 76. Advaxis Company Detail
Table 77. Advaxis Business Overview
Table 78. Advaxis Neoantigen Targeted Therapy Product
Table 79. Advaxis Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 80. Advaxis Recent Development
Table 81. Precision Biologics Company Detail
Table 82. Precision Biologics Business Overview
Table 83. Precision Biologics Neoantigen Targeted Therapy Product
Table 84. Precision Biologics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 85. Precision Biologics Recent Development
Table 86. Gilead Sciences Company Detail
Table 87. Gilead Sciences Business Overview
Table 88. Gilead Sciences Neoantigen Targeted Therapy Product
Table 89. Gilead Sciences Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 90. Gilead Sciences Recent Development
Table 91. Cellular Biomedicine Group Company Detail
Table 92. Cellular Biomedicine Group Business Overview
Table 93. Cellular Biomedicine Group Neoantigen Targeted Therapy Product
Table 94. Cellular Biomedicine Group Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 95. Cellular Biomedicine Group Recent Development
Table 96. Achilles Therapeutics Company Detail
Table 97. Achilles Therapeutics Business Overview
Table 98. Achilles Therapeutics Neoantigen Targeted Therapy Product
Table 99. Achilles Therapeutics Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 100. Achilles Therapeutics Recent Development
Table 101. Merck and Co Company Detail
Table 102. Merck and Co Business Overview
Table 103. Merck and Co Neoantigen Targeted Therapy Product
Table 104. Merck and Co Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 105. Merck and Co Recent Development
Table 106. Beijing Kati Medical Technology Company Detail
Table 107. Beijing Kati Medical Technology Business Overview
Table 108. Beijing Kati Medical Technology Neoantigen Targeted Therapy Product
Table 109. Beijing Kati Medical Technology Revenue in Neoantigen Targeted Therapy Business (2018-2023) & (US$ Million)
Table 110. Beijing Kati Medical Technology Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Neoantigen Targeted Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Neoantigen Targeted Therapy Market Share by Type: 2022 VS 2029
Figure 3. Off-the-shelf Neoantigen Features
Figure 4. Personalized Neoantigen Features
Figure 5. Global Neoantigen Targeted Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Neoantigen Targeted Therapy Market Share by Application: 2022 VS 2029
Figure 7. Colorectal Cancer Case Studies
Figure 8. Renal Cell Carcinoma Case Studies
Figure 9. Non-Small Cell Lung cancer Case Studies
Figure 10. Bone Cancer Case Studies
Figure 11. Gynecological Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Neoantigen Targeted Therapy Report Years Considered
Figure 14. Global Neoantigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Neoantigen Targeted Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Neoantigen Targeted Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Neoantigen Targeted Therapy Market Share by Players in 2022
Figure 18. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapy Revenue in 2022
Figure 20. North America Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 22. United States Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 26. Germany Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2029)
Figure 34. China Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 42. Mexico Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 46. Turkey Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. BioNTech SE Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 49. Gritstone Bio Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 50. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 51. Moderna Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 52. Agenus Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 53. Immatics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 54. Advaxis Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 55. Precision Biologics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 56. Gilead Sciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 57. Cellular Biomedicine Group Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 58. Achilles Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 59. Merck and Co Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 60. Beijing Kati Medical Technology Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Global Neoantigen Targeted Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Neoantigen Targeted Therapy Market Share by Type: 2022 VS 2029
Figure 3. Off-the-shelf Neoantigen Features
Figure 4. Personalized Neoantigen Features
Figure 5. Global Neoantigen Targeted Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Neoantigen Targeted Therapy Market Share by Application: 2022 VS 2029
Figure 7. Colorectal Cancer Case Studies
Figure 8. Renal Cell Carcinoma Case Studies
Figure 9. Non-Small Cell Lung cancer Case Studies
Figure 10. Bone Cancer Case Studies
Figure 11. Gynecological Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Neoantigen Targeted Therapy Report Years Considered
Figure 14. Global Neoantigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Neoantigen Targeted Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Neoantigen Targeted Therapy Market Share by Region: 2022 VS 2029
Figure 17. Global Neoantigen Targeted Therapy Market Share by Players in 2022
Figure 18. Global Top Neoantigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapy as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapy Revenue in 2022
Figure 20. North America Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 22. United States Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 26. Germany Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Neoantigen Targeted Therapy Market Share by Region (2018-2029)
Figure 34. China Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 42. Mexico Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Neoantigen Targeted Therapy Market Share by Country (2018-2029)
Figure 46. Turkey Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Neoantigen Targeted Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. BioNTech SE Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 49. Gritstone Bio Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 50. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 51. Moderna Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 52. Agenus Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 53. Immatics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 54. Advaxis Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 55. Precision Biologics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 56. Gilead Sciences Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 57. Cellular Biomedicine Group Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 58. Achilles Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 59. Merck and Co Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 60. Beijing Kati Medical Technology Revenue Growth Rate in Neoantigen Targeted Therapy Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
